[1] SACKS D,BAXTER B,CAMPBELL B C V,et al.Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke[J].Int J Stroke,2018,13(6):612-632.
[2] ALDIRI I,XU B,WANG L,et al.The dynamic epigenetic landscape of the retina during development,reprogramming,and tumorigenesis[J].Neuron,2017,94(3):550-568.
[3] HOUTKOOPER R H,CANTO C,WANDERS R J,et al.The secret life of NMNAT1:an old metabolite controlling new metabolic signaling pathways[J].Endocr Rev,2010,31(2):194-223.
[4] NIKIFOROV A,KULIKOVA V,ZIEGLER M.The human NAD metabolome:functions,metabolism and compartmentalization[J].Crit Rev Biochem Mol Biol,2015,50(4):284-297. A.质谱法评估NMNAT1敲除组小鼠视网膜中糖酵解、三羧酸循环和肌酐代谢物的相对丰度;B.根据(A) 中代谢物变化着色的糖酵解/三羧酸循环途径(二磷酸果糖酶催化的步骤用单星号表示, GAPDH催化的步骤用双星号标记) 图3 NMNAT1敲除组小鼠视网膜组织糖酵解、三羧酸循环和肌酐代谢的变化 A.Mass spectrometry was used to assess the relative abundance of glycolysis, TCA cycle and creatinine metabolites in the retinas of NMNAT1 knockout group mice;B.Glycolysis/tricarboxylic acid cycle pathway coloured according to metabolite changes in(A)(steps catalysed by fructokinase diphosphate were indicated with a single asterisk, whereas those catalysed by GAPDH were marked with a double asterisk) Fig 3 Changes of glycolysis, tricarboxylic acid cycle and creatinine metabolism in retinal tissues of NMNAT1 knockout group mice 图4 NMNAT1敲除组小鼠(-/-)和对照组(+/+)糖酵解和三羧酸循环相关酶表达水平的热图 Fig 4 Heat map of glycolysis and tricarboxylic acid cycle-related enzyme expression levels in NMNAT1 knockout mice(-/-) and controls(+/+) 图5 NMNAT1敲除组小鼠视网膜组织磷酸戊糖途径代谢物相对丰度的特异性改变 Fig 5 Specifically alteration of the relative abundance of pentose phosphate pathway metabolites in the retinal tissues of NMNAT1 knockout mice
[5] CAMBRONNE X A,KRAUS W L.Location,Location,Location:Compartmentalization of NAD(+) synthesis and functions in mammalian cells[J].Trends Biochem Sci,2020,45(10):858-873.
[6] LIN JONATHAN B,KUBOTA S,BAN N,et al.NAMPT-mediated NMNAT1 biosynthesis is essential for vision in mice[J].Cell Rep,2016,17(1):69-85.
[7] BOWNE S J,SULLIVAN L S,MORTIMER S E,et al.Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis[J].Invest Ophthalmol Vis Sci,2006,47(1):34-42
[8] ALEMAN T S,UYHAZI K E,SERRANO L W,et al.RDH12 Mutations cause a severe retinal degeneration with relatively spared rod function[J].Invest Ophthalmol Vis Sci,2018,59(12):5225-5236.
[9] PERRAULT I,HANEIN S,ZANLONGHI X,et al.Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy[J].Nat Genet,2012,44(9):975-777.
[10] COPPIETERS F,TODESCHINI A L,FUJIMAKI T,et al.Hidden genetic variation in LCA9-associated congenital blindness explained by 5'UTR mutations and copy-number variations of NMNAT1[J].Hum Mutat,2015,36(12):1188-1196.
[11] CHRISTIANSEN J R,KOLANDAIVELU S,BERGO M O,et al.RAS-converting enzyme 1-mediated endoproteolysis is required for trafficking of rod phosphodiesterase 6 to photoreceptor outer segments[J].Proc Natl Acad Sci U S A,2011,108(21):8862-8866.
[12] GRENELL A,WANG Y,YAM M,et al.Loss of MPC1 reprograms retinal metabolism to impair visual function[J].Proc Natl Acad Sci U S A,2019,116(9):3530-3535.
[13] FALK M J,ZHANG Q,NAKAMARU-OGISO E,et al.NMNAT1 mutations cause Leber congenital amaurosis[J].Nat Genet,2012,44(9):1040-1045.
[14] KOENEKOOP R K,WANG H,MAJEWSKI J,et al.Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration[J].Nat Genet,2012,44(9):1035-1039.
[15] SASAKI Y,MARGOLIN Z,BORGO B,et al.Characterization of Leber congenital amaurosis-associated NMNAT1 mutants[J].J Biol Chem,2015,290(28):17228-17238.
[16] CHIANG P W,WANG J,CHEN Y,et al.Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis[J].Nat Genet,2012,44(9):972-974.
[17] NASH B M,SYMES R,GOEL H,et al.NMNAT1 variants cause cone and cone-rod dystrophy[J].Eur J Hum Genet,2018,26(3):428-433.
[18] GREENWALD S H,CHARETTE J R,STANISZEWSKA M,et al.Mouse models of NMNAT1-Leber congenital amaurosis(LCA9) recapitulate key features of the human disease[J].Am J Pathol,2016,186(7):1925-1938.
[19] KURIBAYASHI H,BABA Y,IWAGAWA T,et al.Roles of NMNAT1 in the survival of retinal progenitors through the regulation of pro-apoptotic gene expression via histone acetylation[J].Cell Death Dis,2018,9(9):891.
[20] EBLIMIT A,ZANEVELD S A,LIU W,et al.NMNAT1 E257K variant,associated with Leber congenital amaurosis(LCA9),causes a mild retinal degeneration phenotype[J].Exp Eye Res,2018,173(8):32-43.
[21] CONFORTI L,JANECKOVA L,WAGNER D,et al.Reducing expression of NMNAT1 synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration[J].FEBS J,2011,278(15):2666-2679.
[22] SASAKI Y,ENGBER T M,HUGHES R O,et al.cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy,compromised,and degenerating axons[J].Exp Neurol,2020,329(7):113252.
[23] LUNDT S,ZHANG N,LI J L,et al.Metabolomic and transcriptional profiling reveals bioenergetic stress and activation of cell death and inflammatory pathways in vivo after neuronal deletion of NAMPT[J].J Cereb Blood Flow Metab,2021,41(8):2116-2131.
[24] NG S K,WOOD J P,CHIDLOW G,et al.Cancer-like metabolism of the mammalian retina[J].Clin Exp Ophthalmol,2015,43(4):367-376. |